Literature DB >> 7532778

High-calorie total parenteral nutrition reduces hepatic insulin-like growth factor-I mRNA and alters serum levels of insulin-like growth factor-binding protein-1, -3, -5, and -6 in the rat.

D M Ney1, H Yang, S M Smith, T G Unterman.   

Abstract

High-calorie total parenteral nutrition (TPN) is associated with hepatic dysfunction and steatosis. Because TPN-induced steatosis might compromise hepatic expression of insulin-like growth factor-I (IGF-I) and thereby limit its potential nutritional benefit, we examined hormonal and IGF-I responses in male Sprague-Dawley rats (270 to 300 g) fed by continuous intravenous infusion with high-calorie, high-dextrose (350 kcal/kg) TPN solutions for O (control), 2, 4, and 8 days. Since IGF-binding proteins (IGFBPs) are thought to modulate the biological effects of IGFs in target tissues, we also determined serum levels of IGFBPs. Animals developed hepatic steatosis after 2 to 8 days of TPN, as reflected by a sevenfold to 15-fold increase in hepatic triacylglycerol content (P < .001 v control on each day). Serum corticosterone and insulin levels were significantly higher after 2 and 4 days of TPN, whereas serum growth hormone levels were reduced after 4 and 8 days. Serum IGF-I levels were not significantly different during TPN. However, there was a coordinate reduction in the three major hepatic IGF-I transcripts (7.0, 1.9, and 1.0 kb) after 2, 4, or 8 days of TPN, and IGF-I transcripts corresponding to multiple initiation sites within exons 1 and 2 were coordinately downregulated with TPN. Western ligand blotting indicated that serum levels of 38K to 43K, 30K to 34K, and 24K IGFBPs were increased approximately twofold after 4 and 8 days of TPN as compared with control values.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7532778     DOI: 10.1016/0026-0495(95)90258-9

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  8 in total

1.  Exogenous GLP-2 and IGF-I induce a differential intestinal response in IGF binding protein-3 and -5 double knockout mice.

Authors:  Sangita G Murali; Adam S Brinkman; Patrick Solverson; Wing Pun; John E Pintar; Denise M Ney
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-01-26       Impact factor: 4.052

2.  Sustained glucagon-like peptide-2 infusion is required for intestinal adaptation, and cessation reverses increased cellularity in rats with intestinal failure.

Authors:  Matthew C Koopmann; Xueyan Chen; Jens J Holst; Denise M Ney
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-09-23       Impact factor: 4.052

3.  Nutritional insult and recovery in the neonatal rat cerebellum: insulin-like growth factors (IGFs) and their binding proteins (IGFBPs).

Authors:  G E Shambaugh; N Natarajan; M L Davenport; D Oehler; T Unterman
Journal:  Neurochem Res       Date:  1995-04       Impact factor: 3.996

4.  Choleretic actions of insulin-like growth factor-I, prednisolone, and ursodeoxycholic acid in rats.

Authors:  Miyuki Mabuchi; Ikuo Kawamura; Mariko Fushimi; Shigeru Takeshita; Shoji Takakura; Jiro Hirosumi; Seitaro Mutoh
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199

5.  Colonic GLP-2 is not sufficient to promote jejunal adaptation in a PN-dependent rat model of human short bowel syndrome.

Authors:  Matthew C Koopmann; Xiaowen Liu; Christopher J Boehler; Sangita G Murali; Jens J Holst; Denise M Ney
Journal:  JPEN J Parenter Enteral Nutr       Date:  2009-07-30       Impact factor: 4.016

6.  Enteral nutrients potentiate the intestinotrophic action of glucagon-like peptide-2 in association with increased insulin-like growth factor-I responses in rats.

Authors:  Xiaowen Liu; Sangita G Murali; Jens J Holst; Denise M Ney
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-10-01       Impact factor: 3.619

7.  Insulin-like growth factor-(IGF)-axis, inflammation, and glucose intolerance among older adults.

Authors:  Swapnil N Rajpathak; Aileen P McGinn; Howard D Strickler; Thomas E Rohan; Michael Pollak; Anne R Cappola; Lewis Kuller; XiaoNan Xue; Anne B Newman; Elsa S Strotmeyer; Bruce M Psaty; Robert C Kaplan
Journal:  Growth Horm IGF Res       Date:  2007-09-27       Impact factor: 2.372

8.  Improved nutritional management of phenylketonuria by using a diet containing glycomacropeptide compared with amino acids.

Authors:  Sandra C van Calcar; Erin L MacLeod; Sally T Gleason; Mark R Etzel; Murray K Clayton; Jon A Wolff; Denise M Ney
Journal:  Am J Clin Nutr       Date:  2009-02-25       Impact factor: 7.045

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.